Cita APA

Campioni, M., Agirrezabal, I., Hajek, R., Minarik, J., Pour, L., Spicka, I., . . . Maisnar, V. (2019). Methodology and results of real-world cost-effectiveness of carfilzomib in combination with lenalidomide and dexamethasone in relapsed multiple myeloma using registry data. Eur J Health Econ.

Chicago Style Citation

Campioni, M., I. Agirrezabal, R. Hajek, J. Minarik, L. Pour, I. Spicka, S. Gonzalez-McQuire, P. Jandova, i V. Maisnar. "Methodology and Results of Real-world Cost-effectiveness of Carfilzomib in Combination With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma Using Registry Data." Eur J Health Econ 2019.

Cita MLA

Campioni, M., et al. "Methodology and Results of Real-world Cost-effectiveness of Carfilzomib in Combination With Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma Using Registry Data." Eur J Health Econ 2019.